37 Results
Sort By:
Published on April 3, 2024
Researchers from the Brigham and Women’s Hospital, drawing on a range of research studies of prostate cancer, report that a diagnostic approach combining both MRI with prostate-specific antigen (PSA) density can help doctors avoid performing unnecessary prostate biopsies. The results, published last week in JAMA Network Open provides a new…
Published on August 10, 2022
University of California researchers have demonstrated that annual prostate-specific antigen (PSA) screening may have a greater impact on reducing prostate cancer-specific mortality (PCSM) in Black men than in White men. At present, the U.S. Preventive Services Task Force recommends that, for men aged 55 to 69 years, “the decision to undergo…
Published on April 13, 2022
Incorporating genetic factors that influence prostate-specific antigen (PSA) level into prostate cancer screening may help reduce unnecessary invasive testing and improve the detection of aggressive disease, show data presented at the AACR 2022 annual meeting in New Orleans. Although PSA testing is widely used in prostate cancer diagnosis, population-based PSA…
Published on April 18, 2024
Researchers at the University of Michigan Rogel Cancer Center have announced the development of a novel urine-based test named MyProstateScore2.0 (MPS2), aiming to revolutionize the diagnosis of prostate cancer by identifying high-grade cancers that require immediate intervention. Reporting in JAMA Oncology, the new test could significantly decrease the number of…
Published on November 6, 2023
While it is well documented that Black men in the United States are more likely to develop prostate cancer than White men and have more advanced disease at diagnosis than their White counterparts, limited data is available to help guide prostate-specific antigen (PSA) testing for this at-risk population. Now, new…
Published on April 10, 2023
Disease prevention is a holy grail of medicine. This is particularly true for cancer, where protracted treatment such as surgery, chemotherapy, and radiation can profoundly impact physical and mental quality of life. Genetic testing is increasingly being added to the armamentarium of preventive tools, helping to identify inherited susceptibility before…
Published on March 15, 2023
Prostate cancer rates were lower in men who regularly consumed “colorful fruits and vegetables,” according to new research from the University of South Australia. Nutrients from such a diet were also potentially linked to recovery among men who underwent radiation treatment for the disease. In prostate cancer cases, verses controls,…
Published on January 11, 2023
Prostate specific membrane antigen (PSMA) PET/MRI can determine whether cancer is likely to return within two years after prostatectomy in men recently diagnosed with intermediate or high-grade prostate cancer. Because prostate cancer has widely varying outcomes after treatment, this information could be pivotal in guiding patient management. “PSMA PET/MRI adds…
Published on December 14, 2022
Scientists in Cambridge, England announced that they have created a new tool for predicting an individual’s risk of developing prostate cancer, one that could improve testing accuracy and reduce unnecessary and potentially invasive testing for men at low risk. Developed by a team from the University of Cambridge and The…
Published on December 9, 2022
Researchers at the University of Gothenburg in Sweden have discovered a new diagnostic pathway in screening for prostate cancer, halving the risk of overdiagnosis by finding fewer harmless tumors. Approximately one in eight men will be diagnosed with prostate cancer during his lifetime. Screening for the disease usually involves a…
Published on December 8, 2022
Black men suffer higher rates of prostate cancer, and now research points to genetic variants that may be responsible for early-onset prostate cancer among this population. Researchers at the Wayne State University School of Medicine and the Barbara Ann Karmanos Cancer Institute have found putative markers of the disease in…
Published on November 30, 2022
Research carried out at Wayne State and Duke University Schools of Medicine has identified 26 unique genetic variants in Black men that appear to be associated with more severe prostate cancer in this population group. Prostate cancer is the most common cancer diagnosed in adult men in the U.S. Although…
Published on June 15, 2022
By Luis Enrique Cortés-Hernández & Catherine Alix-Panabières Cancer is a progressive disease, this means that cancer cells have the capacity to replicate significantly faster than normal cells, thus all of their internal cellular mechanisms become oriented to the only selfish aim of replication and survival1. In a similar fashion to animal…
Published on March 15, 2022
Black men with prostate cancer may respond well to androgen deprivation therapy (ADT)-based regimens, but they are less likely to receive such therapy than non-Blacks, according to a new multi-institutional retrospective analysis. The study also found that black men with metastatic hormone-sensitive prostate cancer (mHSPC) are more likely to carry…
Published on December 1, 2021
About 5,000 years ago, Egyptians recognized cancer, but lacked effective treatments. So for centuries and centuries, scientists and clinicians have searched for improved cancer care and ways to evaluate the results. But detecting the disease at low levels remains challenging. Oncologists seek noninvasive but sensitive and accurate methods of detecting…